SUFENTANIL (SUFENTANIL CITRATE) — all Canadian products
5 DINs
3 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is SUFENTANIL (SUFENTANIL CITRATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02483181 | SUFENTANIL CITRATE INJECTION | HIKMA CANADA LIMITED | Solution | Intravenous; Epidural | SUFENTANIL (SUFENTANIL CITRATE) 50 MCG | Approved | |
| 02244147 | SUFENTANIL CITRATE INJECTION USP | SANDOZ CANADA INCORPORATED | Solution | Intravenous; Epidural | SUFENTANIL (SUFENTANIL CITRATE) 50 MCG | Marketed | |
| 02442213 | SUFENTANIL CITRATE INJECTION USP | STERIMAX INC | Solution | Epidural; Intravenous | SUFENTANIL (SUFENTANIL CITRATE) 50 MCG | Marketed | |
| 00619744 | SUFENTA INJ 50MCG/ML | JANSSEN PHARMACEUTICA, DIVISION OF JANSSEN-ORTHO INC. | Liquid | Intravenous | SUFENTANIL (SUFENTANIL CITRATE) 50 MCG | Cancelled Post Market | |
| 01951319 | SUFENTA INJ 50MCG/ML | JANSSEN INC | Liquid | Epidural; Intravenous | SUFENTANIL (SUFENTANIL CITRATE) 50 MCG | Cancelled Post Market |
Browse other molecules: